With $58M in hand, the startup team at Pandion sets their sights on a next-gen approach to immunology

With $58M in hand, the startup team at Pandion sets their sights on a next-gen approach to immunology – Endpoints News

Endpoints NewsAnthony Coyle started Pfizer’s Centers for Therapeutic Innovation with an eye to changing the way the pharma giant went about the business of drug discovery. And then after leaving last summer and joining the great migration out of Big Pharma, he …Cambridge biotech startup names two top leadersThe Boston Globe all 6 news articles […]

from WordPress http://ift.tt/2DmzRYP
via IFTTT